Clinical trial
Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer
NCT00233389 · Otsuka Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00233389 |
|---|---|
| Title | Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer |
| Official title | A Post-marketing Clinical Study of Rebamipide to Investigate the Gastric Ulcer Healing Effect of Continued Dosing Following Helicobacter Pylori Eradication Therapy |
| Lead sponsor | Otsuka Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Stomach Ulcer |
| Intervention type | Drug |
| Interventions | Rebamipide |
| Enrollment | 301 |
| Start date | Apr 30, 2004 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 9, 2005 |
| First posted | Oct 5, 2005 |
| Last update posted | Jun 4, 2021 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: